Skip to Main Content
Phase II

PrecISE: Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network

  • Study HIC#:2000026205
  • Last Updated:07/15/2021

Researchers at Yale University are conducting a study to find new treatments for severe asthma that is sponsored by the National Institutes of Health

The Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network Study (“PrecISE”) is screening people with severe asthma. You may be eligible to participate in the PrecISE Study if you meet certain criteria.

Multiple treatments will be tested in a placebo controlled randomized trial. Each participant will participate in at least 2 treatment periods (up to 5 treatment periods).

  • Age18 years and older
  • GenderBoth
  • Start Date08/21/2020
  • End Date06/30/2023

Eligibility Criteria

Inclusion Criteria:

  • 18 years and older 
  • Severe Asthma

For more information about this study, contact:

Or contact the Help us Discover team on: